Hamster, a close model for visceral leishmaniasis: Opportunities and challenges
- PMID: 32594532
- DOI: 10.1111/pim.12768
Hamster, a close model for visceral leishmaniasis: Opportunities and challenges
Abstract
Aim: Visceral leishmaniasis (VL) caused by parasites belonging to genus Leishmania (L.) is classified as a category I disease by the TDR/WHO. The understanding of the pathogenesis of this disease was built from the findings of available experimental models. Among all available models, the Syrian hamster (Mesocricetus auratus) is the most suitable model for the experimental representation of VL. In this review, we have focused on the opportunities and challenges of using the hamster as an experimental model for visceral leishmaniasis.
Methods: The studies referenced in this review were based on searches in PubMed and Google Scholar without a specific timeline. We collected study results underlining the clinicopathological response, immunopathogenesis and factors determining the outcome of VL in hamsters. Particular emphasis was given in the context of developing new therapeutics and testing potential candidates for vaccine development.
Conclusion: Among all animal models, M. auratus is undoubtedly a better animal model for immunopathogenesis, drug discovery and vaccine development studies of VL infection. But, further optimization of this animal model is required to mimic human VL completely.
Keywords: Mesocricetus auratus; animal model for visceral leishmaniasis; clinicopathological features; drug discovery; immunopathogenesis; vaccine research.
© 2020 John Wiley & Sons Ltd.
References
REFERENCES
-
- Hotez PJ. Nuclear weapons and neglected diseases: the “ten-thousand-to-one gap”. PLoS Negl Trop Dis. 2010;4(4):e680.
-
- Badaro R, Jones TC, Lorenco R, et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis. 1986;154(4):639-649.
-
- Anstead GM, Chandrasekar B, Zhao W, Yang J, Perez LE, Melby PC. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun. 2001;69(8):4709-4718.
-
- Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27:305-318.
-
- Mukhtar MM, Sharief AH, El Saffi SH, et al. Detection of antibodies to Leishmania donovani in animals in a kala-azar endemic region in eastern Sudan: a preliminary report. Trans R Soc Trop Med Hyg. 2000;94(1):33-36.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources